We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
YSELTY (Theramex Australia Pty Ltd)
Product name
YSELTY
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
174 (175 working days)
Active ingredients
linzagolix choline
Registration type
NCE/NBE
Indication
YSELTY is indicated for the management of heavy menstrual bleeding (HMB) associated with uterine fibroids.